Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
13.80
-0.12 (-0.83%)
At close: Aug 25, 2025, 4:00 PM
13.80
+0.01 (0.04%)
After-hours: Aug 25, 2025, 4:19 PM EDT

Theravance Biopharma Statistics

Total Valuation

TBPH has a market cap or net worth of $694.73 million. The enterprise value is $402.39 million.

Market Cap694.73M
Enterprise Value 402.39M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

TBPH has 50.36 million shares outstanding. The number of shares has increased by 0.54% in one year.

Current Share Class 50.36M
Shares Outstanding 50.36M
Shares Change (YoY) +0.54%
Shares Change (QoQ) +2.05%
Owned by Insiders (%) 7.52%
Owned by Institutions (%) 43.65%
Float 21.89M

Valuation Ratios

The trailing PE ratio is 53.92 and the forward PE ratio is 28.38.

PE Ratio 53.92
Forward PE 28.38
PS Ratio 8.86
Forward PS 9.34
PB Ratio 3.09
P/TBV Ratio 3.09
P/FCF Ratio 2.84
P/OCF Ratio 2.84
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 30.88
EV / Sales 5.21
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 1.64

Financial Position

The company has a current ratio of 6.70, with a Debt / Equity ratio of 0.21.

Current Ratio 6.70
Quick Ratio 6.60
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF 0.19
Interest Coverage -13.82

Financial Efficiency

Return on equity (ROE) is 6.23% and return on invested capital (ROIC) is -8.71%.

Return on Equity (ROE) 6.23%
Return on Assets (ROA) -5.65%
Return on Invested Capital (ROIC) -8.71%
Return on Capital Employed (ROCE) -9.59%
Revenue Per Employee $795,928
Profits Per Employee $134,340
Employee Count97
Asset Turnover 0.20
Inventory Turnover n/a

Taxes

In the past 12 months, TBPH has paid $27.05 million in taxes.

Income Tax 27.05M
Effective Tax Rate 67.49%

Stock Price Statistics

The stock price has increased by +70.52% in the last 52 weeks. The beta is 0.01, so TBPH's price volatility has been lower than the market average.

Beta (5Y) 0.01
52-Week Price Change +70.52%
50-Day Moving Average 11.54
200-Day Moving Average 9.96
Relative Strength Index (RSI) 76.71
Average Volume (20 Days) 443,659

Short Selling Information

The latest short interest is 4.12 million, so 8.19% of the outstanding shares have been sold short.

Short Interest 4.12M
Short Previous Month 3.95M
Short % of Shares Out 8.19%
Short % of Float 18.83%
Short Ratio (days to cover) 25.56

Income Statement

In the last 12 months, TBPH had revenue of $77.21 million and earned $13.03 million in profits. Earnings per share was $0.26.

Revenue77.21M
Gross Profit 36.54M
Operating Income -35.63M
Pretax Income -38.22M
Net Income 13.03M
EBITDA -33.96M
EBIT -35.63M
Earnings Per Share (EPS) $0.26
Full Income Statement

Balance Sheet

The company has $338.80 million in cash and $46.46 million in debt, giving a net cash position of $292.35 million or $5.80 per share.

Cash & Cash Equivalents 338.80M
Total Debt 46.46M
Net Cash 292.35M
Net Cash Per Share $5.80
Equity (Book Value) 224.85M
Book Value Per Share 4.46
Working Capital 311.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $245.02 million and capital expenditures -$239,000, giving a free cash flow of $244.78 million.

Operating Cash Flow 245.02M
Capital Expenditures -239,000
Free Cash Flow 244.78M
FCF Per Share $4.86
Full Cash Flow Statement

Margins

Gross margin is 47.33%, with operating and profit margins of -46.16% and 16.88%.

Gross Margin 47.33%
Operating Margin -46.16%
Pretax Margin 51.91%
Profit Margin 16.88%
EBITDA Margin -43.99%
EBIT Margin -46.16%
FCF Margin 317.05%

Dividends & Yields

TBPH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.54%
Shareholder Yield -0.54%
Earnings Yield 1.88%
FCF Yield 35.23%

Analyst Forecast

The average price target for TBPH is $21.33, which is 54.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target $21.33
Price Target Difference 54.62%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 26.58%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TBPH has an Altman Z-Score of -0.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.9
Piotroski F-Score 6